Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

The current inability of psychiatric medicine to objectively select the most appropriate treatment or to predict imminent relapse are major factors contributing to the severity and clinical burden of schizophrenia. We have previously used multiplexed immunoassays to show that schizophrenia patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, E, Guest, P C, Steiner, J, Bogerts, B, Bahn, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309553/
https://www.ncbi.nlm.nih.gov/pubmed/22832819
http://dx.doi.org/10.1038/tp.2012.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309553/
https://www.ncbi.nlm.nih.gov/pubmed/22832819
http://dx.doi.org/10.1038/tp.2012.3

Ejemplares similares